MD Mednax Inc

  1. Stocks
  2. Healthcare
  3. NYSE: MD

Price (delayed)

$22.45

Market cap

$1.84B

P/E Ratio

10.74

Dividend/share

N/A

EPS

$2.09

Enterprise value

$2.27B

?
Relative Growth: Rel. Growth: 72
Relative Strength: Rel. Strength: 71
Relative Valuation: Rel. Valuation: 97
Relative Profitability: Rel. Profitability: 83

Mednax, Inc. is a national medical group comprised of the nation's leading providers of physician services. Physicians and advanced practitioners practicing as part of Mednax are reshaping the delivery of ...

Highlights
The gross margin has grown by 12% year-on-year
The equity is up by 11% YoY
The quick ratio has declined by 26% year-on-year and by 21% since the previous quarter
The P/E is 2.5% above the last 4 quarters average of 10.2
Sector: Healthcare
Industry: Medical Care Facilities
Website: http://www.mednax.com
Peers: THC UHS CYH

Key stats

What are the main financial stats of MD

MD stock price

How has the Mednax stock price performed over time
Intraday
2.79%
1 week
3.89%
1 month
0.18%
1 year
61.51%
YTD
4.96%
QTD
4.96%

Financial performance

How have Mednax's revenue and profit performed over time
Revenue
$1.93B
Gross profit
$504.03M
Operating income
$218.37M
Net income
$174.22M
Gross margin
26.1%
Net margin
9%
The gross margin has grown by 12% year-on-year
Mednax's gross profit has increased by 9% YoY and by 2.1% from the previous quarter
MD's operating income is up by 4.6% since the previous quarter
The net income rose by 5% since the previous quarter

Price vs fundamentals

How does MD's price correlate with its fundamentals

Growth

What is Mednax's growth rate over time

Valuation

What is Mednax stock price valuation
MD P/E details
P/E
10.74
P/B
2.12
P/S
0.94
EV/EBIT
8.65
EV/EBITDA
7.96
EV/Sales
1.17
The company's EPS rose by 6% QoQ
The P/E is 2.5% above the last 4 quarters average of 10.2
The P/B is 21% above the 5-year quarterly average of 1.7 and 14% above the last 4 quarters average of 1.8
The equity is up by 11% YoY
The stock's price to sales (P/S) is 30% more than its 5-year quarterly average of 0.7 and 14% more than its last 4 quarters average of 0.8
The revenue has decreased by 2.3% YoY

Efficiency

How efficient is Mednax business performance
The ROIC is up by 12% from the previous quarter
The ROA has grown by 5% from the previous quarter
The company's return on sales rose by 3% QoQ
MD's return on equity is up by 2.6% since the previous quarter

Dividends

What is MD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MD.

Financial health

How did Mednax financials performed over time
The total assets is 74% greater than the total liabilities
The company's current ratio fell by 27% YoY and by 20% QoQ
The quick ratio has declined by 26% year-on-year and by 21% since the previous quarter
The debt is 28% less than the equity
MD's debt to equity is down by 13% year-on-year
The equity is up by 11% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.